Related Experiment Videos
Bleomycin primes monocytes-macrophages for superoxide production
D O Slosman1, P M Costabella, M Roth
1Nuclear Medicine Division, Hôpital Cantonal Universitaire, Geneva, Switzerland.
The European Respiratory Journal
|July 1, 1990
Summary
Bleomycin (BLM) causes lung inflammation by targeting monocytes-macrophages. These cells show increased superoxide production, contributing to lung tissue injury in early-stage pulmonary fibrosis.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Immunology
Background:
- Bleomycin (BLM) is known to induce lung inflammation and fibrosis in humans and animal models.
- Monocytes-macrophages are hypothesized to be key target cells for BLM toxicity during early pulmonary inflammation.
Purpose of the Study:
- To investigate the role of monocytes-macrophages in the early stages of bleomycin-induced lung injury.
- To examine the effects of BLM on monocyte-macrophage respiratory burst activity in vivo.
Main Methods:
- Developed a rat model (BLM-rats) with systemic BLM administration over 5 days.
- Utilized light and electron microscopy to examine lung tissue.
- Assessed superoxide (O2-) production by alveolar macrophages and circulating monocytes in response to stimuli.
Main Results:
- BLM-rats showed decreased body weight and serum angiotensin converting enzyme activity.
- Electron microscopy revealed intracapillary polymorphonuclear leucocytes and eosinophils, but no fibrosis.
- Alveolar macrophages and circulating monocytes from BLM-rats exhibited significantly increased superoxide production.
Conclusions:
- Monocytes-macrophages are likely target cells in early bleomycin toxicity.
- Increased superoxide production by these cells contributes to tissue injury in pulmonary fibrosis.